Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.
Gandhi RT, Bosch RJ, Aga E, Albrecht M, Demeter LM, Dykes C, Bastow B, Para M, Lai J, Siliciano RF, Siliciano JD, Eron JJ; AIDS Clinical Trials Group A5173 Team. Gandhi RT, et al. Among authors: siliciano jd, siliciano rf. J Infect Dis. 2010 Jan 15;201(2):293-6. doi: 10.1086/649569. J Infect Dis. 2010. PMID: 20001856 Free PMC article. Clinical Trial.
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.
Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J, Siliciano RF. Finzi D, et al. Among authors: siliciano jd, siliciano rf. Nat Med. 1999 May;5(5):512-7. doi: 10.1038/8394. Nat Med. 1999. PMID: 10229227
Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir.
Lori F, Jessen H, Lieberman J, Finzi D, Rosenberg E, Tinelli C, Walker B, Siliciano RF, Lisziewicz J. Lori F, et al. Among authors: siliciano rf. J Infect Dis. 1999 Dec;180(6):1827-32. doi: 10.1086/315113. J Infect Dis. 1999. PMID: 10558937 Clinical Trial.
Antiretroviral resistance during successful therapy of HIV type 1 infection.
Martinez-Picado J, DePasquale MP, Kartsonis N, Hanna GJ, Wong J, Finzi D, Rosenberg E, Gunthard HF, Sutton L, Savara A, Petropoulos CJ, Hellmann N, Walker BD, Richman DD, Siliciano R, D'Aquila RT. Martinez-Picado J, et al. Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10948-53. doi: 10.1073/pnas.97.20.10948. Proc Natl Acad Sci U S A. 2000. PMID: 11005867 Free PMC article.
Latency and viral persistence in HIV-1 infection.
Siliciano JD, Siliciano RF. Siliciano JD, et al. Among authors: siliciano rf. J Clin Invest. 2000 Oct;106(7):823-5. doi: 10.1172/JCI11246. J Clin Invest. 2000. PMID: 11018068 Free PMC article. No abstract available.
355 results